Do you want to skip to content? Skip to content
България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾
False /oidc-signin/en-gb/ България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾

Infusion Care Learning

Guide for healthcare professionals

Welcome to your go-to resource for using Neria™ infusion sets to support the
subcutaneous delivery of medications.*

Go through each section step-by-step, or navigate using the tabs

*Please refer to the instructions for use that come with the Neria™ infusion sets for intended use and indications.
The choice of medication and method of administration rely on the assessment of healthcare professionals.

Start Learning
Introduction

Introduction

What is subcutaneous infusion and where is Neria™ indicated?

Subcutaneous infusion continuously delivers medication over a longer period - in the fatty tissue beneath the skin.

On this page: Indications    FAQ's

What is subcutaneous infusion?

Subcutaneous infusion continuously delivers medication over a longer period into fatty tissue beneath the skin, where the body absorbs it. A needle penetrates the skin, leaving either the needle or a soft catheter in the tissue for up to 72 hours.

Needles and cannulas can vary in length, size, features and method of insertion. Using an infusion set for continuous subcutaneous infusion requires fewer injections (insertions) compared to injection therapy.

diagram, schematic ;
  1. Infusion pump
  2. Tubing
  3. Infusion set with needle and adhesive

The specific treatment set-up and type of medication is always determined by a healthcare professional.

Where is Neriaâ„¢ indicated for use?

Our Neria™ infusion sets are approved for the subcutaneous infusion of medications in conditions such as Parkinson’s disease, palliative pain, management, immunodeficiencies and thalassemia. (5)

Palliative care

Pain management is an important part of end of life care for individuals with serious illnesses where the aim is to improve quality of life. (1)

Parkinsons

Parkinson’s disease is a movement disorder of the nervous system that worsens over time. Certain treatments can be administered subcutaneously to provide a steady level of medication in the body. (2)

Immunodeficiencies

Subcutaneous infusion can deliver immunoglobulin (antibodies) under the skin to treat immunodeficiencies, which refers to a group of either inherited (primary immunodeficiencies) or acquired disorders that prevent the body’s immune system from working properly. (3)

Thalassemia

A heterogeneous group of blood disorders that affect haemoglobin, thalassemia results in iron overload and can be treated using iron chelating drugs delivered subcutaneously. (4)

Common Questions Answered

Neria™ infusion sets are medical devices designed for subcutaneous drug delivery. The infusion set is located in the subcutaneous tissues and connects the pump or syringe to the body.

The components of an infusion set include:

  • Needle and/or cannula – the cannula is inserted under the skin using an introducer needle
  • Adhesive – built-in and adhesive pad
  • Tubing - Double layer tubing designed to be strong, kink free and transparent (5)
  • Luer lock connector – a standard connector to the syringe or pump

The Neria™ range of infusion sets come with either soft catheters or steel needles for the subcutaneous delivery of medications. The sets have been designed to be compatible with certain drugs approved for subcutaneous infusion for the treatment of Parkinson’s disease, primary Immunodeficiency, pain management, and thalassaemia.(5)

Stability testing has been carried out with the following drugs(5):

  • Apomorphine and foslevodopa/foscarbidopa for Parkinson’s disease
  • Immunoglobulins for Immune deficiencies
  • Morphine and hydromorphone for pain management
  • Desferal™ for thalassemia

What’s next?

1. NHS, Greater Manchester Health and Social Care Partnership. Palliative care pain and symptom control guidelines for adults. https://www.england.nhs.uk/north-west/wp-content/uploads/sites/48/2020/01/Palliative-<br>Care-Pain-and-Symptom-Control-Guidelines.pdf Accessed 13 August 2025 .

2. Kukkle PL, et al. Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson&amp;#39;s Disease: A Systematic Review. Mov Disord Clin Pract. 2023 Jun 26;10(9):1253-1267.

3. Immune deficiency foundation. https://primaryimmune.org/understanding-primary-immunodeficiency/treatment/immunoglobulin-replacement-therapy Accessed: 13 August 2025.

4. NHS, Imperial College Healthcare. Desferrioxamine (Desferal&reg;): Information for patients, relatives and carers. https://www.imperial.nhs.uk/-/media/website/patient-information-leaflets/haematology/red-blood-cell-<br>disease/desferrioxamine.pdf?rev=1e57547aede64035abf00de0d04612f7&amp;amp;sc_lang=en Accessed 13 August 2025.

5. Core Claims Table Convatec IC, data on file, D012-002912, 2023

2. Our devices

Neria™

Get to know our infusion sets

A basic infusion set includes an insertion needle, adhesive pad, tubing and a luer-lock connector. The specific features of each Neria™ infusion set vary, and the right set will depend on your preferences and your patient’s treatment needs.

On this page: Components    How to use    Compare Real stories    FAQ’s

Your choice for simplifying subcutaneous infusion

The Neria™ infusion sets are designed and approved for subcutaneous infusion in the treatment of diseases such as Parkinson’s disease, thalassemia, primary immune deficiency and pain management.*

*Convatec IC, data on file, D012-002912, 2023.

Neria™ infusion sets offer:

  • Thin needles (G27)
  • Built-in adhesive
  • Double-layer, small bore tubing to minimise drug waste and priming volumes*
  • Reduced risk of needle stick injury (with Neria™ Guard)*
  • Tubing disconnect at the infusion site on Neria™ Guard and Neria™ Soft
  • Standard luer-lock connection

Key components of an infusion set

All Neriaâ„¢ infusion sets feature the same basic components. Neriaâ„¢ Guard has an additional feature, which is a fully automatic insertion device. Below you can read about all the components of an infusion set incl. the inserter.
a close-up of a stethoscope and a stethoscope ;
  1. Cannula housing
    A plastic housing with a soft cannula or steel needle that is attached to the skin by an adhesive tape.
  2. Soft cannula or steel needle
    A small soft cannula or steel needle that is
    inserted into the subcutaneous skin layer and that allows the medication or fluid to flow into the body.
  3. Tubing
    A plastic tube that allows the medication or fluid to flow from the pump to the body.
  4. Site connector
    A connector that clicks into the cannula housing and connects the plastic tubing to the infusion set. It allows for temporary disconnection of the pump. (only for Neria™ Guard and Neria™ Soft)

How to use

Follow this simple step-by-step guide when using the Neriaâ„¢ Guard automatic inserter and infusion set.

Start with Neria Guard

Step 1: Select and prepare the site

After washing your hands, clean the insertion site and leave to air dry. Note: You may need to remove hair from the area so the adhesive can properly attach to the skin.

icon ;

Step 2: Prepare Neria™ Guard

Open the Neria™ Guard package and take out the contents. Gently remove the paper from the adhesive, being careful not to touch the adhesive.

a pair of hands holding a white object ;

Step 3: Remove the safeguard

Squeeze the sides of the tab on the inserter and gently pull it out.

diagram ;

Step 4: Insert the infusion set

Stretch the skin so it is flat and place the insertion device on the skin before pressing the red button completely down. The insertion is complete when the device is released from the cannula housing.

a cartoon of a person ;

Step 5: Secure the adhesive

Press the adhesive tape down onto the skin

diagram ;

Step 6: Connect the tubing to the pump/syringe

Turn the pump connector clockwise and hold the cannula housing in place with your finger while pushing the site connector straight in until you hear a "click".

diagram ;
;

Video title text

 

 

 

 

Watch the demonstration video

Follow this simple step-by-step guide when using the Neria™ Guard automatic inserter.

Additional instructions for other Neria products

Comparing Neriaâ„¢ infusion sets

 

Header 1

Header 1

Header 1

Header 1

Cannula

 Soft

Stainless Steel

 Soft

 Stainless Steel

Insertion angle

90 degrees

90 degrees

20-45 degrees

90 degrees

Disconnection feature

Yes at site

No

Yes at site

No

Needle / Introducer needle gauge

G27

G27 or G29

G27

G27

Needle lenghts

6 or 9mm

6, 8, 10 or 12mm

13 or 17mm

Bifurcated: 8, 10mm
Trifucated: 8, 10 or 12mm
Quad-furcated: 8, 10, 12mm

Tubbing lenghts

12, 60, 110cm

60, 110cm

60, 110cm

Total 90cm

Adhesive

Built-in

Built-in

Built-in

Built-in

Hidden needle

Yes

-

-

-

Priming volumes

12cm @ 0.04ml
60cm @ 0.10ml
110cm @ 0.15ml

60cm @ 0.10ml
110cm @ 0.15ml

60cm @ 0.10ml
110cm @ 0.15ml

Bifurcated: 0.36ml
Trifucated: 0.43ml
Quad-furcated: 0.51ml

From Health Care Professionals

“The Convatec Neria™ Guard infusion set has transformed my insulin delivery experience. Its reliable adhesive and flexible design provide unmatched comfort and security. I feel confident knowing my medication is delivered effectively.”


Dr Emily Carter, Clinical Specialist

“The Convatec Neria™ Guard infusion set has transformed my insulin delivery experience. Its reliable adhesive and flexible design provide unmatched comfort and security. I feel confident knowing my medication is delivered effectively.”


Dr Emily Carter, Clinical Specialist

Common Questions Answered

It is recommended that a Neria™ infusion set is changed after 72 hours for a soft catheter or 48 hours for a steel needle. Please consult the instructions for use that comes with the product for further information.

No. The Neria™ infusion sets are specifically designed for subcutaneous drug delivery and are not intended for IV infusion of medication.

Neria™ Guard is an infusion set with an integrated needle safe and fully automatic inserter. The user cannot see and is not exposed to the needle at any time, which can help protect the user from needle stick injuries.

Neria™ infusion sets have a standard luer lock connector and are compatible with most available infusion pumps.

The strong, double layer tubing included with Neria™ infusion sets is designed to be kink-resistant. (Reference: Core Claims Table Convatec IC, data on file, D012-002912, 2023)

When disconnecting the tubing, you can use the caps to give a smoother surface at the site (cannula housing). The caps are included in the soft-catheter infusion sets (Neria™Guard and Neria™Soft).

Below are the approximate priming volumes for each tubing length. Please read the instructions for use that come with the product.

Tubing Length Priming volume
12cm ~ 0.04ml
30cm ~ 0.06ml
60cm

~ 0.10ml

80cm ~ 0.12ml
110cm ~ 0.15ml

Neria™ infusion sets come with different needle sizes and tubing lengths, making them suitable for all patient types. For maximum absorption of subcutaneous drugs,
the needle or soft catheter should be positioned in the adipose fat layer below the skin.

The choice of soft cannula or needle length should be based on treatment and patient-specific factors such as physiology and activity level. A soft cannula or needle that is too long may result in insertion pain and/or insertion into a bone or muscle and a soft cannula or needle that is too short could result in leakage or irritation at the insertion site.

For very lean and active patients, a shorter needle or Neria™Soft with an angled insertion may be more suitable. The different tubing lengths also accommodate the needs of patients and the position of the pump.

Please always consult drug requirements and the pump manufacturer’s instructions for use prior to choosing the appropriate infusion set.

What’s next?

3. Techniques

Techniques

How to select and manage infusion sites

The following guidance can help you find the best places to insert an infusion set and how to rotate the insertion site to minimise any potential skin irritation.(1)(2)

On this page: Techniques    Troubleshooting    Test your knowledge    FAQ’s

a pink and purple cartoon character ;

Typical insertion sites are on your lower back, abdomen, hips, buttocks, thigh or upper arm. Consider also cannula length when selecting the optimal insertion site for your patient.

Insertion tips:

  • Make sure the site is clean and dry.
  • Avoid sites in contact with constrictive clothing, such as a waistband, or other objects that can pull on the infusion set.
  • Avoid the navel and surrounding area.
  • Do not select a site that is infected, swollen, red, irritated, bruised or bleeding.
  • Do not insert in an area with lumps, hard tissue or bumps.
  • Do not insert into bone or muscle as this may cause pain, damage the product
    and affect medication absorption.

It is important to not re-use the same insertion site:

  • Use a pattern, such as a clock or snake, to guide the next insertion site placement.
  • Choose a site that is at least 2.5 cm away from the previous site.*
  • Leave the site to rest and do not re-use until the skin has healed.

Remember, the above rotation pattern is an example only. Consult local guidelines
and select the rotation pattern that works best for the individual patient.

*IEADSG Guidelines: Insulin Storage and Optimisation of Injection Technique in Diabetes Management, Diabetes Therapy, (2019) 10:341-366

  • Remember to visually inspect the infusion set and site several times each day.
  • Follow recommended hygiene procedures and ensure the site remains clean and dry.
  • Change the infusion set as per drug indication.
  • Do not use any creams, oils or perfumes on the site.
  • Gently massage the site after use.
  • If nodules occur, consider ultrasound treatment. (Henriksen, Tove, and Harry Staines. “Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease: A Single- Center, Long-Term Follow-Up Study of the Causes for iscontinuation.” Journal of personalized medicine vol. 11,6 525. 8 Jun. 2021.)

Frequently asked questions

The most commonly used insertion sites for subcutaneous therapy are on the abdomen and lower back. Please read the product’s instructions for use and consider any local guidelines and protocols.

Some tips which may help reduce the risk of infusion site irritation include:

  • Always clean and dry the insertion site prior to insertion.
  • Massage the insertion site prior to insertion.=
  • Monitor the insertion site through the “window” of the soft catheter infusion set.
  • Make sure to rotate the sites for instance by using a rotation pattern.
  • Consider switching to a soft cannula infusion set and/or a shorter needle when faced with insertion site problems.
  • If site irritation occurs, change the infusion set to a new site and massage the skin.
    Disclaimer: Please always refer to the instruction for use which comes with the product for further information and guidance.

Many factors can influence the condition of your skin. To help minimise skin complications, consider the following:

  • Remember skin and hand hygiene prior to insertion.
  • Use new areas for insertion, for instance the lower back and thighs.
  • Use a rotation pattern to avoid re-using the same site.
  • Avoid sites that already have site irritation or nodules.
  • Use a site that does not interfere with clothing, belts etc.
  • Massage the infusion site prior to insertion.
  • Change the catheter material (from steel to soft), length or insertion technique.
    Disclaimer: Please always refer to the instruction for use which comes with the product for further information and guidance.

What’s next?

1. Hagell, Peter et al. “Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease.” Journal of Neurology vol. 267,11 (2020): 3411-3417.
2. Fùˆrst, Per et al. “Continuous subcutaneous infusion for pain control in dying patients: experiences from a tertiary palliative care center.” BMC Palliative Care vol. 19,1 172. 10 Nov 2020.

4. Patient Support

Patient support

Equip your patients with knowledge and confidence

The following guidance can help you explain subcutaneous infusion to patients and answer their most common questions.

On this page: Everyday situations  Common questions

Everyday situations

Sports

Wearing an infusion set doesn’t have to hold your patients back, but it’s important to take precautions to avoid issues like dislodgement or skin irritation.

a man playing basketball ;

Avoid placing the infusion set in a high friction area or in an area with repeated muscle movements. Sweat, movement or impact may dislodge the set or cause irritation.

a hand holding a light bulb ;

It’s generally safe and beneficial to stay as active as possible but always make recommendations based on the specific needs of the patient and as assessed by the healthcare professional.

a group of different sized and shaped packages ;

Showering and bathing

Neria™Guard and Neria™Soft allow for disconnection of the tubing and pump, prior to taking a bath or shower.

a pink flower in a black basket ;

Patients can shower and bathe while wearing the infusion set. However, If the adhesive tape becomes loose, change to a new product and a new site. Check the insertion site frequently to ensure that the soft cannula or needle remain firmly in
place. If it is not in place, change to a new product and a new site.

a faucet on a tile wall ;

Disconnect the infusion pump and tubing (for Neria™ Guard and Neria™ Soft only) before taking a bath or shower and make sure to check the site before reconnecting.

diagram ;

Work & daily life

When choosing an infusion set, consider the patient’s activity level. An infusion set with a disconnect option at site makes it easier for the patient to shower and engage in sports. Consider the availability of custom bags for carrying the pump during activities.

a man and woman holding cups ;

The tubes that come with the infusion sets vary in length. Consider which length is most convenient for the patient and offers the right level of mobility.

a doctor talking to a patient ;

On the go

When travelling, carry infusion sets in hand baggage in case of a delay and remember to carry spare sets.

a woman in a blue dress with a hat and a couple of suitcases ;

Before going through security, disconnect the pump and inform security staff about the infusion pump.

a plane flying over a group of luggage ;

Consider the availability of custom bags for carrying the pump during holiday activities such as hiking and cycling.

a man opening a suitcase ;

Frequently asked questions from patients

Yes, if using a soft catheter infusion set (Neria™Guard or Neria™Soft), the tubing and pump can be disconnected prior to a shower or bath. If the adhesive tape becomes loose, change to a new product and a new site. Check the insertion site frequently to ensure that the soft cannula or steel needle remain firmly in
place. If it is not in place, change to a new product and a new site.

Some tips which may reduce the risk of infusion site pain and irritation include:

  • Always clean and dry the insertion site prior to insertion.
  • Massage the insertion site prior to insertion.
  • Monitor the insertion site through the “window” of the soft catheter infusion set.
  • Make sure to rotate the sites using one of the recommended patterns (for instance S-shape or clockwise).
  • Consider switching to a soft cannula infusion set and/or a shorter needle/soft catheter when faced with insertion site problems.
  • If site irritation occurs, change the infusion set to a new site and massage the skin.
    Disclaimer: Please always refer to the instruction for use which comes with the product for futher information and guidance.

What’s next?

5. Knowledge Centre

Knowledge Centre

Download Fact Cards

Download fact cards

Fact Card 1

PDF

Fact Card 2

PDF

Fact Card 3

PDF

Instruction videos

;

Video title text

Video 1

;

Video 2

;

Video 3

Further resources

Product range brochure

PDF

Site management leaflet

PDF

Pain infographic

PDF

External resources

Subscribe to stay in the know

Newsletter sign up

*Required Fields

*Required Fields

Work Details

Work Details

We need your consent to continue

We need your consent to continue

Consent to Data Processing
Consent to Marketing

You can manage your consent at any time by unsubscribing through a link in our emails or by contacting us by email neria@convatec.com.

You can manage your consent at any time by unsubscribing through a link in our emails or by contacting us by email neria@convatec.com.

Ready to experience the Neriaâ„¢ difference? Order your sample today (for healthcare professionals only)

Order sample

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?